imperatorin has been researched along with Laryngeal Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Dmoszyńska-Graniczka, M; Grabarska, A; Khalifa, S; Kiełbus, M; Klatka, J; Kowalczuk, K; Kupisz, K; Miziak, P; Nowosadzka, E; Polberg, K; Rivero-Müller, A; Skalicka-Woźniak, K; Smok-Kalwat, J; Stepulak, A; Szumiło, J | 1 |
1 other study(ies) available for imperatorin and Laryngeal Neoplasms
Article | Year |
---|---|
Imperatorin as a Promising Chemotherapeutic Agent Against Human Larynx Cancer and Rhabdomyosarcoma Cells.
Topics: Angelica archangelica; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chromatography; Cyclin-Dependent Kinase Inhibitor p21; Drug Screening Assays, Antitumor; Fibroblasts; Flow Cytometry; Fruit; Furocoumarins; Humans; L-Lactate Dehydrogenase; Laryngeal Neoplasms; Pastinaca; Rhabdomyosarcoma | 2020 |